Pekinpharma initiates first major collaboration to transfer its Adalimumab biosimilar turnkey solution

Pekinpharma's collaboration with ATM Medical Group in Indonesia, which enables the local production of biosimilar drugs through knowledge and capacity transfer, signals the potential of Pekinpharma's complete suite of solutions in providing affordable local biosimilar production. The collaboration will help enable a portfolio of biosimilar drugs developed by Pekinpharma, including monoclonal antibodies such as Adalimumab, to serve local manufacturers seeking to deliver essential medicines.